Vor Biopharma, Inc. (VOR)
15.05
+0.10
(+0.67%)
USD |
NASDAQ |
Mar 04, 16:00
14.96
-0.09
(-0.60%)
Pre-Market: 08:31
Vor Biopharma Research and Development Expense (Annual) : 93.31M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| iBio, Inc. | 8.312M |
| Recursion Pharmaceuticals, Inc. | 425.27M |
| Senti Biosciences, Inc. | 33.38M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |